重组果糖二磷酸醛缩酶SjLAP和亮氨酸氨基肽酶SjFBPA用于日本血吸虫病的诊断和疗效考核的评价

来源 :中国寄生虫学与寄生虫病杂志 | 被引量 : 0次 | 上传用户:yangjia14
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的 评价重组亮氨酸氨基肽酶(rSjLAP)和重组果糖二磷酸醛缩酶(rSjFBPA)抗原用于诊断人血吸虫感染以及疗效考核的价值. 方法 异丙基-β-D-硫代半乳糖苷(IPTG)诱导pET-28a-rSjLAP/B L21和pET-28a-rSjFBPA/BL21表达目的蛋白,组氨酸标签亲和纯化柱纯化rSjLAP和rSjFBPA蛋白.88只BALB/c雌性小鼠随机分为4组,A、B和C组(各21只小鼠),D组(25只小鼠).A、B和C组分别感染5、15和25条日本血吸虫尾蚴.D组为不感染对照组,在实验的第1天全部处死.A、B和C组在感染后第3、7、10、14、20、30和60天,分别处死小鼠3只,采眼球血制备血清,检测其抗体水平.采用单独或联合rSjLAP和rSjFBPA为抗原,ELISA法检测小鼠血清、急性血吸虫病(38份)和慢性血吸虫病患者(96份)血清中的抗体,以健康人(90份)血清为对照,同时检测华支睾吸虫病(33份)、卫氏并殖吸虫病(40份)和钩虫病患者(37份)血清,并检测急性血吸虫病患者吡喹酮治疗(60 mg/kg,2次/d×2d)后1年的血清(36份)、慢性血吸虫病患者吡喹酮治疗(剂量,疗程同前)后1年(36份)和2年(64份)的血清. 结果 BALB/c小鼠在感染后第10天,rSjLAP和rSjFBPA单独或联合使用均可检测到小鼠血清中的IgG抗体;B组(0.535±0.053,0.595±0.033,0.696±0.104)和C组(0.548±0.060,0.608±0.063,0.621 ±0.090)早期抗体水平明显高于A组(0.415±0.038,0.455±0.056,0.498±0.077)(P<0.05).用rSjLAP为抗原可检测急性血吸虫病和慢性血吸虫病患者血清,阳性率分别为97.4% (37/38)和87.5% (84/96) (P>0.05);用rSjFBPA为抗原检测,其阳性率分别为94.7% (36/38)和88.5% (85/96) (P>0.05);用rSjLAP和rSjFBPA联合为抗原检测,则其阳性率分别为94.7% (36/38)和85.4% (82/96) (P>0.05).rSjLAP或联合抗原的特异性均为96.7% (87/90),而rSjFBPA的特异性为97.8% (88/90).给予吡喹酮治疗后,rSjLAP和rSjFBPA单独或联合使用检测急性血吸虫病血清(0.236±0.212,0.287±0.191,0.235±0.120)和慢性血吸虫病患者(0.266±0.124,0.261±0.143,0.265±0.140;0.204±0.074,0.176±0.074,0.176±0.073),抗体滴度普遍下降,与对照组(0.188±0.056,0.173±0.045,0.184±0.051)相比,差异无统计学意义(P>0.05).rSjLAP和rSjFBPA单独为抗原检测华支睾吸虫病患者血清,交叉反应率为15.2% (5/33)和12.11% (4/33),两者联合则为9.2% (3/33).rSjLAP检测卫氏并殖吸虫的交叉反应率为15.0% (6/40),rSjFBPA为12.5% (5/40),两种抗原联合检测为15.0% (6/40).上述抗原单独或联合检测钩虫的交叉反应率均为8.1%(3/37).上述各组阳性率与健康人群之间差异有统计学意义(P<0.05),显示该重组抗原在其他蠕虫检测中存在一定的交叉反应. 结论 用rSjFBPA和rSjLAP作为抗原的ELISA法诊断血吸虫病具有良好的敏感性和特异性.“,”Objective To investigate the early response of immunoglobulin G (IgG) antibody responses to Schistosoma japonicum infection in mice by using the recombinant proteins,S.japonicum leucine aminopeptidase (rSjLAP) and S.japonicum fructose-1,6-bisphosphate aldolase (rSjFBPA),and evaluate the potential of rSjLAP and rSjFBPA in diagnosis as well as in assessment of therapeutic efficacy in human schistosomiasis.Methods rSjLAP or rSjFBPA was induced from Escherichia coli BL21 strain transfected with the expression vectors,pET-28a-rSjFBPA/BL21 or pET-28a-rSjLAP/BL21 using isopropyl-β3-D-thiogalactoside (IPTG),and purified by Ni-NTA His Bind resin.88 BALB/c female mice,inbred and 6 to 8 weeks old,were randomly divided into 4 groups.Groups A,B and C each made up of 21 mice and group D comprised 25 mice.Groups A,B and C were infected with 5,15 and 25 S.japonicum cercariae respectively.As control,mice in group D were left uninfected.3 mice from each of groups A,B and C were sacrificed and sera collected on days 3,7,10,14,20,30,and 60 post infection.All the 25 mice in group D were sacrificed on the first day of the experiment for serum collection,rSjLAP and rSjFBPA were screened and used in ELISA to test the antibody response of the serum samples.Also,sera of 38 acute patients,96 chronic patients with schistosomiasis japonica,90 healthy donors and patients with other parasite infections including Clonorchis sinensis (33 cases),Paragonimus westermani (40) and hookworms (37) were tested using the recombinant protein-based ELISA.In addition,36 sera each from the acute and chronic patients 12 months after treatment with praziquantel and 64 of the chronic patients in more than 2 years post-treatme nt of praziquantel were tested.The dosage of praziquantel for both acute and chronic patients was 60 mg/kg,2 times/d×2 d.Results IgG antibody response was first detected at day 10 post infection by rSjLAP,rSjFBPA or the combined antigen assay.The mean absorbance (A450) on this day were 0.535±0.053,0.595±0.033,0.696±0.104 for group B; 0.548±0.060,0.608±0.063,0.621±0.090 for group C; and 0.415±0.038,0.455±0.056,0.498±0.077 for group A for rSjLAP,rSjFBPA and the combined assay respectively (P<0.05).Early antibody level to both antigens was significantly higher in mice infected with 15 or 25 cercariae than those with 5 cercariae (P<0.05).However,ELISA results in patients with confirmed schistosomiasis revealed positive rates of 97.4% (37/38) and 87.5% (84/96) for acute and chronic schistosomiasis with rSjLAP,94.7% (36/38) and 88.5% (85/96) for acute and chronic schistosomiasis with rSjFBPA and 94.7% (36/38)and 85.4%(82/96)with both rSjLAP and rSjFBPA respectively.Statistical analysis showed no significant difference in the positive rate (P>0.05).Also,rSjLAP and combined antigens showed a specificity of 96.7% (87/90) while that of rSjFBPA was 97.8% (88/90).There was a general decrease in the antibody titer of the patients after treatment.In 12 months after treatment it was 0.236±0.212 with rSjLAP,0.287±0.191 with rSjFBPA,and 0.235±0.120 with both antigens respectively for acute cases; For chronic patients,it was 0.266±0.124,0.261±0.143 and 0.265±0.140 in 12 months post-treatment,and 0.204±0.074,0.176±0.074,and 0.176±0.073 in 2 years,respectively.For healthy control,it was 0.188±0.056,0.173±0.45, and 0.184±0.051,respectively.No significant difference on antibody titer was found between treated patients and control (P>0.05).The cross reaction with C.sinensis was 15.2% (5/33) for rSjLAP,12.1% (4/33) for rSjFBPAand 9.2% (3/33) for combined antigens.With P.westermani,it was 15.0% (6/40),12.5% (5/40) and 15.0% (6/40),respectively,and 8.1% (3/37) with hookworm infection.Conclusion The study showed a satisfactory sensitivity and specificity of rSjLAP and rSjFBPA by ELISA which is promising for the immunological diagnosis of schistosomiasis.
其他文献
【摘要】目的探讨中药汤剂在治疗高血脂中的效果,为临床治疗工作给予参考和借鉴。方法以我院2010年04月01日到2013年04月01日收治的高血脂患者60例为研究对象,随机分成两组,对照组和实验组唯一不同就是实验组服用中药汤剂,对照组服用常用于降血脂的脂必妥片。探讨中药汤剂在治疗高血脂中的效果。结果实验组显效14例,好转13例,无效3例,总有效率为90%。中药汤剂治疗高血脂中两组的结果比较,P<0.
期刊
目的:观察弹性髓内钉治疗儿童不稳定型尺桡骨双的效果.方法:分析我院收治的56例儿童不稳定型尺桡骨双骨折患者,根据简单随机原则分为两组,各28例.对照组28例用切开复位钢板内
期刊
@@
【摘要】目的探讨和分析对痤疮患者采取中药面膜结合医学美容外治法进行治疗临床效果和价值。方法选取于2012年06月——2013年09月在我院接受治疗的痤疮患者84例为研究对象,依据标签法随机将上述选取对象分成对照组和观察组,对照组患者给予中药面膜进行治疗,观察组患者在采取上述治疗的基础上,同时应用医学美容外治法进行治疗,观察和对比两组患者治疗效果。结果观察组和对照组总治疗有效率依次分别为100.0%
期刊
目的 :探讨对糖尿病患者应用益气养阴活血汤的治疗效果.方法 :对2017年1月~2018年1月收治的糖尿病患者52例,将患者按照治疗方法不同分为观察组、对照组各26例,对照组采用常规
【摘要】针刀治疗椎动脉型颈椎病,通常病变部位在颈项部太阳经循经部位,以经络循行路线和异常改变的粘连部位作为治疗点,加以手法整复位移的小关节,使椎动脉卡压症状得以解除,是针刀获得较高疗效的基础。  【关键词】椎动脉;中医机理;经络循行路线;针刀;正骨  doi:10.3969/j.issn.1004-7484(s).2014.04.654文章编号:1004-7484(2014)-04-2323-01
期刊
目的:分析中药炮制对中药饮片的化学成分及疗效影响.方法:选取2016年3月至2018年3月在我院接受中药饮片治疗的患者72例,采取随机分组的方式分为A组、B组、C组,各组人数均为24
【摘要】目的观察火针治疗急性淋巴结炎的效果。方法将临床确诊的158例急性淋巴结炎患者用随机数字表法分为两组,每组79例。对照组给予常规西医治疗;治疗组在对照组治疗的基础上加以火针疗法。观察两组临床治疗效果及主要临床指标变化。结果治疗组和对照组病人总有效率分别为96.2%、58.2%,治疗组疗效明显优于对照组,差异有统计学意义。结论火针治疗急性淋巴结炎效果显著,方法简单可靠,值得临床推广。  【关键
期刊
目的:探讨观察依那西普治疗放射学阴性中轴型脊柱关节炎的临床疗效.方法:回顾性分析于2017年2月至2018年7月期间在我院进行治疗的放射学阴性中轴型脊柱关节炎患者100例作为本
目的 观察原位再生医疗技术对Ⅲ、Ⅳ期压疮创面面积及血管内皮生长因子(Vascular Endothelial Growth Factor,VEGF)表达的影响,探讨其促进压疮创面愈合的可能机制.方法 将201